Skip to content
WeighLab
Provider review

Novi Review: Price, Pros & Cons

By The WeighLab Bench, Tools & Data Desk

Novi is a cash-pay GLP-1 telehealth brand selling compounded semaglutide at $129 a month and tirzepatide at $169 a month month-to-month, with lower rates on a 3-month plan and brand-name pens listed from $1,500.

In this review

Compounded drugs are not FDA-approved. Treatment requires a clinician's assessment. Understand compounded GLP-1 treatment.

Check Novi prices Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.

Prices at a glance

Semaglutide
$129/moAll doses, month-to-month, compounded; $99/mo on a 3-month plan billed $297
Tirzepatide
$169/moAll doses, month-to-month, compounded; $139/mo on a 3-month plan billed $417
Coverage
Coverage not published
Brand-name
Yes

Semaglutide · estimated annual cost

$1,548

Tirzepatide · estimated annual cost

$2,028

Who Novi may suit

Shoppers who want one price at every dose and can choose between month-to-month billing and a cheaper 3-month plan.

Where the value is

  • Same price at every dose, with the consult, prescription and shipping included
  • Month-to-month billing is available, so the 3-month plan is a choice rather than a requirement
  • No monthly membership fee and cancel-anytime billing
  • LegitScript certified, with a link to its record in LegitScript's own lookup

The tradeoffs

  • The headline $99 and $139 figures are 3-month-plan rates billed $297 and $417 up front; month-to-month is $129 and $169
  • A countdown timer and "was $299" pricing frame the offer as a promotion, and Novi says promotional pricing may change
  • No state list, medical director or pharmacy is named on its site; the pharmacy appears only in your order emails
  • Its refund policy says it can't accept returns once medication is sent

What Novi charges, month to month and by the quarter

Novi sells compounded semaglutide and tirzepatide at one price for every dose. The big "$99" on its homepage is the 3-month semaglutide rate, billed as $297 every three months. If you'd rather pay one month at a time, semaglutide is $129 a month.

PlanSemaglutideTirzepatide
Month-to-month$129/mo$169/mo
3-month plan$99/mo ($297 billed every 3 months)$139/mo ($417 billed every 3 months)

The price includes the consult, the prescription and shipping. There's no monthly membership fee and you don't need insurance. Novi also offers buy-now-pay-later plans.

The homepage frames all of this as a seasonal promotion, with a countdown clock and "was $299" pricing. Novi's own fine print says promotional pricing is subject to change, so check the total in your cart before you pay.

Considering Novi?

Check the plan total, billing period and cancellation terms before you enroll. A clinician decides whether treatment is appropriate.

Brand-name pens

Novi also lists Mounjaro, Ozempic, Wegovy and Zepbound, each "started at $1500." That's a very different budget from the compounded plans, and Novi doesn't break the brand prices down by dose or say how they're billed. Ask before you choose one.

Who prescribes and who fills it

Novi says it's a technology and administrative company. It doesn't practice medicine or run a pharmacy. Independent U.S.-licensed providers review your free two-minute evaluation and decide whether to prescribe, and treatment is for adults 18 and older.

The medication is made by independent state-licensed pharmacies or outsourcing facilities. Novi doesn't name them up front. They're identified in your order confirmation emails, so look there if you want to know who made your vial. Novi says the whole process, from approval to delivery, usually takes two to three days.

Canceling and refunds

Novi advertises cancel-anytime billing. Its refund policy is short: because of the nature of the products, it can't accept returns. If something goes wrong, it asks you to contact support so it can work out a solution. Support is by email, seven days a week, and medical questions go to your provider through the patient portal.

Things to check before you sign up

  • Decide between month-to-month and the 3-month plan before checkout. The 3-month plan is billed up front.
  • Novi doesn't publish the states it serves. Ask support if you're unsure about yours.
  • Compounded semaglutide and tirzepatide aren't FDA-approved.

The Index scorecard

Novi scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month94/100
Price Transparency94/100
Nationwide Access24/100
Formulation Options79/100
Clinical Oversight87/100
Contract Flexibility55/100

The bottom line

Novi is a cash-pay GLP-1 telehealth brand selling compounded semaglutide at $129 a month and tirzepatide at $169 a month month-to-month, with lower rates on a 3-month plan and brand-name pens listed from $1,500.

Compare the total cost of other GLP-1 programs and alternatives to Novi before deciding. A clinician should help you choose the right treatment.

Other programs to compare with Novi

These are partners: we may earn a commission if you sign up, at no cost to you.

  • Direct MedsPartner

    Semaglutide modeled $249/mo · Tirzepatide modeled $299/mo

    Direct Meds sells semaglutide and tirzepatide both as a sublingual and as an injection, every product priced in the open, from $249 a month on a plan that bills against a 90-day supply.

  • Belle HealthPartner

    Semaglutide modeled $109/mo · Tirzepatide modeled $179/mo

    Belle offers compounded GLP-1 subscriptions with flat dose pricing, licensed clinician care and several named pharmacy partners.

  • WillowPartner

    Semaglutide modeled $299/mo · Tirzepatide modeled $399/mo

    Willow is a direct-to-consumer telehealth provider offering compounded semaglutide and tirzepatide in both injectable and oral-tablet form at identical prices per format.

Compare with other providers

The providers whose Cost-Efficiency Index scores sit closest to Novi's. See the alternatives to Novi.

Explore more provider reviews

Pricing, states and verification reflect Novi's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Novi's site. Not medical advice; see our disclosure.

← Back to the value leaderboard